STOCK TITAN

Funicular Funds, Cable Car Capital stake 5.2% in Nasus Pharma (NSRX)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Nasus Pharma Ltd reports beneficial ownership disclosures. Funicular Funds, LP; Cable Car Capital, LP; and Jacob Ma-Weaver each report beneficial ownership of 612,913 Ordinary Shares, representing 5.2% of the class. The calculation uses 11,710,808 Shares outstanding as of March 27, 2026 per the Post-Effective Amendment No. 1 to Form F-1. Cable Car Capital, LP is identified as general partner of Funicular Funds and Ma-Weaver is the managing member and therefore may be deemed the beneficial owner of the shares held by Funicular Funds.

Positive

  • None.

Negative

  • None.

Insights

Multiple affiliated entities report the same 5.2% stake in Nasus Pharma Ltd.

The filing lists 612,913 shares each for Funicular Funds, Cable Car Capital, LP, and Jacob Ma-Weaver, tied to a single holding vehicle. The disclosure clarifies ownership through a general partner relationship and an individual managing member, which is standard attribution language for pooled‑investment structures.

Watch subsequent filings for any change in reported ownership or conversion of holdings; timing and cash‑flow treatment are not included in this excerpt.

Schedule 13G disclosure filed to report >5% position under passive/beneficial ownership rules.

The submission cites the issuer's Post-Effective Amendment No. 1 to Form F-1 as the basis for the 11,710,808 shares outstanding denominator. The filing attributes sole voting and dispositive power for the reported shares to the named filers.

Filing signatures are dated 04/07/2026; subsequent amendments or Form 13D would be required if the parties take active steps to influence control.

Reported shares per filer 612,913 shares Amount beneficially owned by each filer
Percent of class 5.2% Percent of Ordinary Shares per filer
Shares outstanding used 11,710,808 shares Shares outstanding per Post-Effective Amendment No. 1 to Form F-1 as of <date>March 27, 2026</date>
Schedule 13G regulatory
"Item 1. | (a) | Name of issuer: Nasus Pharma Ltd"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
beneficial ownership financial
"The reporting person's beneficial ownership consists of 612,913 Ordinary Shares"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Post-Effective Amendment No. 1 to Form F-1 regulatory
"as reported by the Issuer in Post-Effective Amendment No. 1 to Form F-1 on March 27, 2026"





M7071P109

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The reporting person's beneficial ownership consists of 612,913 Ordinary Shares (the "Shares"). The foregoing calculation is based upon 11,710,808 Shares outstanding as reported by the Issuer in Post-Effective Amendment No. 1 to Form F-1 with the Securities and Exchange Commission on March 27, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The reporting person's beneficial ownership consists of 612,913 Shares. The foregoing calculation is based upon 11,710,808 Shares outstanding as reported by the Issuer in Post-Effective Amendment No. 1 to Form F-1 with the Securities and Exchange Commission on March 27, 2026. Cable Car Capital, LP, as the General Partner of Funicular Funds, LP, and Jacob Ma-Weaver, as the Managing Member of Cable Car Capital, LP, may each be deemed the beneficial owner of the Shares held by Funicular Funds, LP.


SCHEDULE 13G




Comment for Type of Reporting Person: The reporting person's beneficial ownership consists of 612,913 Shares. The foregoing calculation is based upon 11,710,808 Shares outstanding as reported by the Issuer on Post-Effective Amendment No. 1 to Form F-1 with the Securities and Exchange Commission on March 27, 2026. Cable Car Capital, LP, as the General Partner of Funicular Funds, LP, and Jacob Ma-Weaver, as the Managing Member of Cable Car Capital, LP, may each be deemed the beneficial owner of the Shares held by Funicular Funds, LP.


SCHEDULE 13G



Funicular Funds, LP
Signature:Jacob Ma-Weaver
Name/Title:Managing Member of the General Partner
Date:04/07/2026
Cable Car Capital, LP
Signature:Jacob Ma-Weaver
Name/Title:Managing Member
Date:04/07/2026
Ma-Weaver Jacob
Signature:Jacob Ma-Weaver
Name/Title:Jacob Ma-Weaver
Date:04/07/2026
Exhibit Information

Exhibit A

FAQ

Who filed the Schedule 13G for Nasus Pharma Ltd (NSRX)?

Funicular Funds, LP; Cable Car Capital, LP; and Jacob Ma-Weaver filed the Schedule 13G. The filing lists each as reporting beneficial ownership of 612,913 shares.

How many Nasus Pharma shares does each filer report owning?

Each filer reports beneficial ownership of 612,913 Ordinary Shares. The filing shows sole voting and dispositive power for those 612,913 shares.

What percentage of Nasus Pharma does the 612,913-share stake represent?

The 612,913 shares represent 5.2% of the class. That percentage uses an outstanding share base of 11,710,808 from the issuer's Form F-1 amendment.

What outstanding share count does the filing use for its calculation?

The calculation is based on 11,710,808 Shares outstanding as reported in the Post-Effective Amendment No. 1 to Form F-1 dated March 27, 2026.

Why are Cable Car Capital and Jacob Ma-Weaver described as possibly deemed beneficial owners?

Cable Car Capital, LP is the general partner of Funicular Funds and Jacob Ma-Weaver is its managing member. That structure may cause them to be deemed beneficial owners of Funicular Funds' holdings.